Machine learning-based plasma proteomics discovers biomarkers for the early diagnosis of Parkinson’s disease

Parkinson’s disease (PD) is a progressive neurodegenerative disorder, yet reliable and minimally invasive biomarkers for accurate diagnosis and clinical stratification remain lacking. Here, we aimed to identify plasma-based protein biomarkers with diagnostic and differential utility for PD. Plasma samples from 391 participants were analyzed using a two-stage design. In the discovery phase, label-free quantitative proteomics identified differentially expressed proteins between patients with PD and healthy controls, followed by functional enrichment analyses. A machine learning–based feature selection strategy was used to derive candidate biomarker panels. In the validation phase, selected proteins were quantified by enzyme-linked immunosorbent assay in an independent cohort including patients with PD, patients with multiple system atrophy, Parkinsonian type (MSA-P), and healthy controls. Diagnostic performance was evaluated using receiver operating characteristic analyses, and associations with clinical features were examined. Proteomic profiling identified 121 differentially expressed proteins related to vesicle trafficking, oxidative stress, and autophagy. A plasma protein panel comprising LAMP1, APOD, VIM, CTSF, and HEG1 showed robust performance in distinguishing PD from healthy controls, while a simplified combination moderately differentiated PD from MSA-P. Selected biomarkers were also associated with clinical scales of cognition and non-motor symptoms, supporting the potential utility in the clinical assessment of PD.

Authors

Institutions

Publication Details

Journal
npj Parkinson s Disease
Published
2026-11-17
DOI
https://doi.org/10.1038/s41531-026-01606-2
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Machine learning-based plasma proteomics discovers biomarkers for the early diagnosis of Parkinson’s disease

Yuming Xu, Jing-Hua Yang, Minglei Liu, Tianyuan Yang et al.
2 links
npj Parkinson s Disease
Parkinson's Disease Mechanisms and Treatments
article

Machine learning-based plasma proteomics discovers biomarkers for the early diagnosis of Parkinson’s disease

Yuming Xu, Jing-Hua Yang, Minglei Liu, Tianyuan Yang, Yanpeng Yuan, Ruoyu Liu, Ke Zhang, Xiaojing Liu, Jing Yang, Jing yuan, Liyuan Fan, Jie Qin, Lanjun Li, Ying Kong
article en

Abstract

Parkinson’s disease (PD) is a progressive neurodegenerative disorder, yet reliable and minimally invasive biomarkers for accurate diagnosis and clinical stratification remain lacking. Here, we aimed to identify plasma-based protein biomarkers with diagnostic and differential utility for PD. Plasma samples from 391 participants were analyzed using a two-stage design. In the discovery phase, label-free quantitative proteomics identified differentially expressed proteins between patients with PD and healthy controls, followed by functional enrichment analyses. A machine learning–based feature selection strategy was used to derive candidate biomarker panels. In the validation phase, selected proteins were quantified by enzyme-linked immunosorbent assay in an independent cohort including patients with PD, patients with multiple system atrophy, Parkinsonian type (MSA-P), and healthy controls. Diagnostic performance was evaluated using receiver operating characteristic analyses, and associations with clinical features were examined. Proteomic profiling identified 121 differentially expressed proteins related to vesicle trafficking, oxidative stress, and autophagy. A plasma protein panel comprising LAMP1, APOD, VIM, CTSF, and HEG1 showed robust performance in distinguishing PD from healthy controls, while a simplified combination moderately differentiated PD from MSA-P. Selected biomarkers were also associated with clinical scales of cognition and non-motor symptoms, supporting the potential utility in the clinical assessment of PD.

npj Parkinson s Disease
Zhengzhou University (CN), Peking University First Hospital (CN), First Affiliated Hospital of Zhengzhou University (CN)
National Natural Science Foundation of China, Natural Science Foundation of Henan Province, First Affiliated Hospital of Zhengzhou University
Good health and well-being
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon